Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Donepezil 10mg tablets
0411000D0AAABAB
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 340,066 |
|
Donepezil 5mg tablets
0411000D0AAAAAA
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 127,952 |
|
Donepezil 10mg orodispersible tablets sugar free
0411000D0AAAEAE
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 10,244 |
|
Donepezil 5mg orodispersible tablets sugar free
0411000D0AAADAD
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 4,645 |
|
Donepezil 1mg/ml oral solution sugar free
0411000D0AAAJAJ
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 1,115 |
|
Donepezil 10mg orodispersible tablets
0411000D0AAAIAI
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 231 |
|
Donepezil 5mg orodispersible tablets
0411000D0AAAHAH
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | 85 |
|
Donepezil 10mg/5ml oral suspension
0411000D0AAAFAF
|
Donepezil hydrochloride | Donepezil hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.